12/5
11:44 am
ew
Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says [Yahoo! Finance]
Low
Report
Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says [Yahoo! Finance]
12/5
10:58 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at UBS Group AG.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at UBS Group AG.
12/5
09:47 am
ew
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Royal Bank Of Canada from $95.00 to $100.00. They now have an "outperform" rating on the stock.
Low
Report
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Royal Bank Of Canada from $95.00 to $100.00. They now have an "outperform" rating on the stock.
12/5
08:43 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Stifel Nicolaus.
12/5
08:43 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at Truist Financial Corporation.
12/5
08:43 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $89.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $89.00 price target on by analysts at Canaccord Genuity Group Inc..
12/5
08:09 am
ew
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Robert W. Baird from $83.00 to $88.00. They now have a "neutral" rating on the stock.
Low
Report
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Robert W. Baird from $83.00 to $88.00. They now have a "neutral" rating on the stock.
12/5
07:21 am
ew
Edwards Lifesciences (NYSE:EW) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Edwards Lifesciences (NYSE:EW) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
12/5
07:21 am
ew
Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
12/4
07:02 pm
ew
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at BTIG Research.
Low
Report
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at BTIG Research.
12/4
09:42 am
ew
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference [Yahoo! Finance]
Low
Report
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference [Yahoo! Finance]
12/4
09:00 am
ew
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
Low
Report
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
12/3
11:14 am
ew
Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
11/30
03:29 pm
ew
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Low
Report
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
11/27
07:42 pm
ew
Edwards Lifesciences (EW) Earnings Transcript [Yahoo! Finance]
Low
Report
Edwards Lifesciences (EW) Earnings Transcript [Yahoo! Finance]
11/25
08:07 am
ew
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $100.00 price target on the stock.
Low
Report
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $100.00 price target on the stock.
11/11
09:09 am
ew
Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish? [Yahoo! Finance]
Low
Report
Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish? [Yahoo! Finance]
11/9
04:22 pm
ew
Driving Timely Diagnosis And Treatment For Heart Valve Disease To Save Lives [Yahoo! Finance]
Low
Report
Driving Timely Diagnosis And Treatment For Heart Valve Disease To Save Lives [Yahoo! Finance]
11/9
04:21 pm
ew
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease [Yahoo! Finance]
Low
Report
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease [Yahoo! Finance]
11/9
04:00 pm
ew
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
Low
Report
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
11/3
10:42 am
ew
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Truist Financial Corporation from $87.00 to $90.00. They now have a "hold" rating on the stock.
Low
Report
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Truist Financial Corporation from $87.00 to $90.00. They now have a "hold" rating on the stock.
11/3
08:15 am
ew
Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
11/3
08:07 am
ew
Edwards Lifesciences (NYSE:EW) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Low
Report
Edwards Lifesciences (NYSE:EW) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
11/3
08:07 am
ew
Edwards Lifesciences (NYSE:EW) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Edwards Lifesciences (NYSE:EW) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
11/3
05:02 am
ew
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Raymond James Financial, Inc. from a "market perform" rating to an "outperform" rating.
Low
Report
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Raymond James Financial, Inc. from a "market perform" rating to an "outperform" rating.